Drug profile · INN
fenofibric acid
FIBRICOR
fenofibric acid (FIBRICOR) is a peroxisome proliferator-activated receptor alpha agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — fenofibric acid
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
fenofibric acid (FIBRICOR) is a peroxisome proliferator-activated receptor alpha agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Peroxisome proliferator-activated receptor alpha agonist
Primary target: Peroxisome proliferator-activated receptor alpha
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is fenofibric acid?
fenofibric acid (FIBRICOR) is a peroxisome proliferator-activated receptor alpha agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for fenofibric acid?
FIBRICOR is a marketed brand name for fenofibric acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fenofibric acid?
fenofibric acid has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.